Understanding and overcoming major barriers in cancer nanomedicine.
作者信息
Nie Shuming
出版信息
Nanomedicine (Lond). 2010 Jun;5(4):523-8. doi: 10.2217/nnm.10.23.
Abstract
摘要
相似文献
1
Understanding and overcoming major barriers in cancer nanomedicine.理解并克服癌症纳米医学中的主要障碍。
Nanomedicine (Lond). 2010 Jun;5(4):523-8. doi: 10.2217/nnm.10.23.
2
New Strategies in the Design of Nanomedicines to Oppose Uptake by the Mononuclear Phagocyte System and Enhance Cancer Therapeutic Efficacy.新型纳米药物设计策略以抵制单核吞噬细胞系统摄取并增强癌症治疗效果。
Chem Asian J. 2018 Nov 16;13(22):3333-3340. doi: 10.1002/asia.201800149. Epub 2018 Mar 30.
3
Competition Between Tumor and Mononuclear Phagocyte System Causing the Low Tumor Distribution of Nanoparticles and Strategies to Improve Tumor Accumulation.肿瘤与单核吞噬细胞系统的竞争导致纳米颗粒在肿瘤部位的低分布和提高肿瘤积累的策略。
Curr Drug Deliv. 2016;13(8):1261-1274. doi: 10.2174/1567201813666160418105703.
4
Phagocytosis of colloidal carbon by the reticuloendothelial system during hepatocarcinogenesis in rats.
Proc Soc Exp Biol Med. 1961 Oct;108:216-9. doi: 10.3181/00379727-108-26896.
5
Liposomes of Quantum Dots Configured for Passive and Active Delivery to Tumor Tissue.量子点脂质体经被动和主动递送至肿瘤组织的构建。
Nano Lett. 2019 Sep 11;19(9):5844-5852. doi: 10.1021/acs.nanolett.9b01027. Epub 2019 Aug 22.
6
Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots.纳米材料的药代动力学：碳纳米管、富勒烯和量子点概述。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Jan-Feb;1(1):26-34. doi: 10.1002/wnan.24.
7
[Lipofundin clearance test. Rate of phagocytosis activity in the reticuloendothelial system].
Med Klin. 1973 Jan 12;68(2):48-53.
8
Estimation of RES phagocytosis and catabolism in man by the use of 125I-labeled microaggregates of human serum albumin.利用125I标记的人血清白蛋白微聚体对人体中网状内皮系统（RES）的吞噬作用和分解代谢进行评估。
J Reticuloendothel Soc. 1975 Sep;18(3):151-9.
9
Reticulo-endothelial phagocytosis in patients with nephritis.肾炎患者的网状内皮吞噬作用
Br Med J. 1976 Feb 7;1(6005):321. doi: 10.1136/bmj.1.6005.321.
10
Measurement of reticuloendothelial system phagocytosis and catabolism: a new method.
J Reticuloendothel Soc. 1969 Aug;6(4):333-43.
引用本文的文献
1
Metal coordination polymer nanoparticles for cancer therapy.用于癌症治疗的金属配位聚合物纳米颗粒。
Essays Biochem. 2025 Apr 10;69(2):EBC20253012. doi: 10.1042/EBC20253012.
2
Pharmacokinetic and ADMET Profiles of Synthetic Antimicrobial Peptides (AMPs).合成抗菌肽（AMPs）的药代动力学和ADMET特性
Mini Rev Med Chem. 2025;25(8):579-590. doi: 10.2174/0113895575362479241231054240.
3
Enhanced Persistent Luminescence from Cr-Doped ZnGaO Nanoparticles upon Immersion in Simulated Physiological Media.掺杂铬的ZnGaO纳米颗粒浸入模拟生理介质后增强的持久发光。
Nanomaterials (Basel). 2025 Feb 6;15(3):247. doi: 10.3390/nano15030247.
4
Microfluidics-Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle-Vesicle Hybrids.微流控驱动的纳米颗粒-囊泡杂化物的制造及多尺度分析表征
Adv Healthc Mater. 2025 Feb;14(4):e2403264. doi: 10.1002/adhm.202403264. Epub 2024 Dec 25.
5
Renally Excretable Molybdenum Disulfide Nanoparticles as Contrast Agents for Dual-Energy Mammography and Computed Tomography.可经肾脏排泄的二硫化钼纳米颗粒作为双能乳腺X线摄影和计算机断层扫描的造影剂
Bioconjug Chem. 2024 Dec 18;35(12):2006-2014. doi: 10.1021/acs.bioconjchem.4c00508. Epub 2024 Dec 4.
6
Berberine-styrene--maleic acid nanomicelles: unlocking opportunities for the treatment and prevention of bacterial infections.小檗碱-苯乙烯-马来酸纳米胶束：为治疗和预防细菌感染带来机遇
RSC Adv. 2024 Oct 28;14(46):34066-34080. doi: 10.1039/d4ra04457f. eCollection 2024 Oct 23.
7
Development and Characterization of a Peptide-Bisphosphonate Nanoparticle for the Treatment of Breast Cancer.肽-双膦酸盐纳米颗粒的制备及用于乳腺癌治疗的研究。
Mol Pharm. 2024 Oct 7;21(10):4970-4982. doi: 10.1021/acs.molpharmaceut.4c00299. Epub 2024 Aug 28.
8
Anticancer activity of quantum size carbon dots: opportunities and challenges.量子尺寸碳点的抗癌活性：机遇与挑战
Discov Nano. 2024 Aug 5;19(1):122. doi: 10.1186/s11671-024-04069-7.
9
Oral delivery of nanomedicine for genetic kidney disease.纳米药物经口服用于治疗遗传性肾病
PNAS Nexus. 2024 May 10;3(5):pgae187. doi: 10.1093/pnasnexus/pgae187. eCollection 2024 May.
10
Antibody-displaying extracellular vesicles for targeted cancer therapy.抗体展示的细胞外囊泡用于靶向癌症治疗。
Nat Biomed Eng. 2024 Nov;8(11):1453-1468. doi: 10.1038/s41551-024-01214-6. Epub 2024 May 20.
本文引用的文献
1
Tissue-penetrating delivery of compounds and nanoparticles into tumors.化合物和纳米颗粒向肿瘤的组织穿透递送。
Cancer Cell. 2009 Dec 8;16(6):510-20. doi: 10.1016/j.ccr.2009.10.013.
2
Next-generation quantum dots.下一代量子点
Nat Biotechnol. 2009 Aug;27(8):732-3. doi: 10.1038/nbt0809-732.
3
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.纳米颗粒逃避网状内皮系统：支撑双层膜的作用。
Biochim Biophys Acta. 2009 Oct;1788(10):2259-66. doi: 10.1016/j.bbamem.2009.06.022. Epub 2009 Jul 10.
4
Understanding biophysicochemical interactions at the nano-bio interface.理解纳米-生物界面的生物物理化学相互作用。
Nat Mater. 2009 Jul;8(7):543-57. doi: 10.1038/nmat2442. Epub 2009 Jun 14.
5
Nanomedicine--challenge and perspectives.纳米医学——挑战与展望。
Angew Chem Int Ed Engl. 2009;48(5):872-97. doi: 10.1002/anie.200802585.
6
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.纳米颗粒的大小和表面性质决定了蛋白质冠层，这可能对生物影响产生潜在影响。
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70. doi: 10.1073/pnas.0805135105. Epub 2008 Sep 22.
7
Does a targeting ligand influence nanoparticle tumor localization or uptake?靶向配体是否会影响纳米颗粒在肿瘤中的定位或摄取？
Trends Biotechnol. 2008 Oct;26(10):552-8. doi: 10.1016/j.tibtech.2008.06.007. Epub 2008 Aug 21.
8
Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands.使用多功能多齿聚合物配体使量子点的流体动力学尺寸最小化。
J Am Chem Soc. 2008 Aug 27;130(34):11278-9. doi: 10.1021/ja804306c. Epub 2008 Aug 5.
9
Seven challenges for nanomedicine.纳米医学面临的七大挑战。
Nat Nanotechnol. 2008 May;3(5):242-4. doi: 10.1038/nnano.2008.114.
10
Immunological properties of engineered nanomaterials.工程纳米材料的免疫特性
Nat Nanotechnol. 2007 Aug;2(8):469-78. doi: 10.1038/nnano.2007.223. Epub 2007 Jul 29.
Zotero 插件